Effect of face mask design on inhaled mass of nebulized albuterol, using a pediatric breathing model

Respiratory Care

Volumn 52, Issue 8, 2007, Pages 1021-1026

  Lin, Hui Ling ^a   Restrepo, Ruben D ^b   Gardenhire, Douglas S ^c   Rau, Joseph L ^c  

^a DAKOTA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Aerosol; Albuterol; Face mask; Inhaled drug mass; Jet nebulizer; Pediatric

Indexed keywords

SALBUTAMOL;

AEROSOL; ARTICLE; ATMOSPHERE; BREATHING; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; FACE MASK; FILTER; NEBULIZATION; NEBULIZER; SIMULATION; STATISTICAL SIGNIFICANCE; AUDIOVISUAL EQUIPMENT; EQUIPMENT DESIGN; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG VOLUME; MATERIALS TESTING; PEDIATRICS; UNITED STATES;

ADMINISTRATION, INHALATION; ALBUTEROL; EQUIPMENT DESIGN; HUMANS; LUNG VOLUME MEASUREMENTS; MANIKINS; MATERIALS TESTING; MODELS, ANATOMIC; NEBULIZERS AND VAPORIZERS; PEDIATRICS; RESPIRATION; UNITED STATES;

EID: 35148877421     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hess D. Nebulizers: principles and performance. Respir Care 2000; 45(6):609-622.
2. Collies GG, Cole CH, LeSouef PN. Dilution of nebulised aerosols by air entrainment in children. Lancet 1990;336(8711):341-343.
3. Iles R, Lister P, Edmunds AT. Crying significantly reduces absorption of aerosolised drug in infants. Arch Dis Child 1999;81(2):163-165.
4. Restrepo RD, Dickson SK, Rau JL, Gardenhire DS. An investigation of nebulized bronchodilator delivery using a pediatric lung model of spontaneous breathing. Respir Care 2006;51(1):56-61.
5. Everard ML, Clark AR, Milner AD. Drug delivery from jet nebulizers. Arch Dis Child 1992;67(5):586-591.
6. Hayden JT, Smith N, Woolf DA, Barry PW, O'Callaghan C. A randomised crossover trial of facemask efficacy. Arch Dis Child 2004;89(1):72-73.
7. Amirav I, Mansour Y, Mandelberg A, Bar-Ilan I, Newhouse MT. Redesigned facemask improves "real life" aerosol delivery for Nebuchamber. Pediatr Pulmonol 2004;37(2):172-177.
8. Shah SA, Berlinski AB, Rubin BK. Force-dependent static dead space of face masks used with holding chambers. Respir Care 2006;51(2):140-144.
9. Amirav I, Newhouse MT. Aerosol therapy with valved holding chambers in young children: importance of the face mask seal. Pediatrics 2001;108(2):389-394.
10. Amirav I, Mansour Y, Mandelberg A, Bar-Ilan I, Newhouse MT. Redesigned face mask improves "real life" aerosol delivery for Nebuchamber. Pediatr Pulmonol 2004;37(2):172-177.
11. Esposito-Festen JE, Ates B, van Vliet FJ, Verbraak AF, de Jongste JC, Tiddens HA. Effect of a facemask leak on aerosol delivery from a pMDI-spacer system. J Aerosol Med 2004;17(1):1-6.
12. Smaldone GC. Drug delivery via aerosol systems: concept of "aerosol inhaled." J Aerosol Med 1991;4(3):229-235.
13. Kirk RE. Experimental design: procedures for the behavioral sciences. Belmont CA: Brooks/Cole Publishing Co; 1994:237-244.
14. Cortina JM, Nouri H. Effect size for ANOVA designs. Iowa City: Sage Publications; 2000:1.
15. Sangwan S, Gurses BK, Smaldone GC. Facemasks and facial deposition of aerosols. Pediatr Pulmonol 2004;37(5):447-452.
16. Smaldone GC, Berg E, Nikander K. Variation in pediatric aerosol delivery: importance of facemask. J Aerosol Med 2005;18(3):354-363.
17. Shakked T, Broday DM, Katoshevski D, Amirav I. Administration of aerosolized drugs to infants by a hood: a three-dimensional numerical study. J Aerosol Med 2006;19(4):533-542.
18. Rau JL, Ari A, Restrepo RD. Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric. Respir Care 2004;49(2):174-179.